Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000428745 | SCV000522962 | likely benign | not specified | 2017-05-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000580519 | SCV000682229 | likely benign | Hereditary cancer-predisposing syndrome | 2016-02-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002065032 | SCV002369195 | likely benign | Ataxia-telangiectasia syndrome | 2024-11-24 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003492041 | SCV004240758 | uncertain significance | Breast and/or ovarian cancer | 2022-08-24 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004591193 | SCV005082925 | likely benign | Familial cancer of breast | 2024-05-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |
German Consortium for Hereditary Breast and Ovarian Cancer, |
RCV005090755 | SCV005848175 | uncertain significance | Hereditary breast ovarian cancer syndrome | 2025-01-14 | criteria provided, single submitter | curation | According to the ClinGen ACMG ATM v1.3.0 criteria we chose this criterion: BP4 (supporting benign): SpliceAI shows impact on splicing. |
Clinical Genetics Laboratory, |
RCV001692095 | SCV001905858 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001692095 | SCV001954801 | likely benign | not provided | no assertion criteria provided | clinical testing |